Deconvolution of bulk tumors into distinct immune cell states predicts colorectal cancer recurrence
Donghyo Kim,
Jinho Kim,
Juhun Lee,
Seong Kyu Han,
Kwanghwan Lee,
JungHo Kong,
Yeon Jeong Kim,
Woo Yong Lee,
Seong Hyeon Yun,
Hee Cheol Kim,
Hye Kyung Hong,
Yong Beom Cho,
Donghyun Park,
Sanguk Kim
Affiliations
Donghyo Kim
Department of Life Sciences, Pohang University of Science and Technology, Pohang 790-784, Korea
Jinho Kim
Precision Medicine Center, Future Innovation Research Division, Seoul National University Bundang Hospital, Seongnam13620, Korea
Juhun Lee
Department of Life Sciences, Pohang University of Science and Technology, Pohang 790-784, Korea
Seong Kyu Han
Department of Life Sciences, Pohang University of Science and Technology, Pohang 790-784, Korea
Kwanghwan Lee
Department of Life Sciences, Pohang University of Science and Technology, Pohang 790-784, Korea
JungHo Kong
Department of Life Sciences, Pohang University of Science and Technology, Pohang 790-784, Korea
Yeon Jeong Kim
Samsung Genome Institute, Samsung Medical Center, Seoul06351, Korea
Woo Yong Lee
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul06351, Korea
Seong Hyeon Yun
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul06351, Korea
Hee Cheol Kim
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul06351, Korea
Hye Kyung Hong
Institute for Future Medicine, Samsung Medical Center, Seoul06351, Korea
Yong Beom Cho
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul06351, Korea; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul06351, Korea; Corresponding author
Department of Life Sciences, Pohang University of Science and Technology, Pohang 790-784, Korea; Institute of Convergence Science, Yonsei University, Seoul120-749, Korea; Corresponding author
Summary: Predicting colorectal cancer recurrence after tumor resection is crucial because it promotes the administration of proper subsequent treatment or management to improve the clinical outcomes of patients. Several clinical or molecular factors, including tumor stage, metastasis, and microsatellite instability status, have been used to assess the risk of recurrence, although their predictive ability is limited. Here, we predicted colorectal cancer recurrence based on cellular deconvolution of bulk tumors into two distinct immune cell states: cancer-associated (tumor-infiltrating immune cell-like) and noncancer-associated (peripheral blood mononuclear cell-like). Prediction model performed significantly better when immune cells were deconvoluted into two states rather than a single state, suggesting that the difference in cancer recurrence was better explained by distinct states of immune cells. It indicates the importance of distinguishing immune cell states using cellular deconvolution to improve the prediction of colorectal cancer recurrence.